Coggin J H
Department of Microbiology and Immunology, University of South Alabama, College of Medicine, Mobile 36688.
Mol Biother. 1989;1(4):223-8.
Immunization of adult, syngeneic BALB/c mice with irradiated, primary MCA-induced sarcomas conferred reproducible, nonisologous TATA-associated cross-protection against challenge with other primary MCA sarcomas or in vitro passaged MCA sarcoma cells. Isologous, individually specific TSTA-associated protection was also detected. Irradiated, normal BALB/c spleen or muscle tissues were not similarly protective. Pronounced cross-protection was best detected with secondary cultured, in vitro adapted sarcoma challenge inoculum, which could be accurately standardized. These findings paralleled the good cross-protection reported previously with long-term cultured MCA-induced sarcoma cell lines. OFA was expressed as a TATA on all syngeneic, primary MCA-induced sarcomas tested by syngeneic adoptive transfer experiments and on MuLv-free MCA-induced, syngeneic Meth A sarcoma cells.
用经辐照的、原发性甲基胆蒽(MCA)诱导的肉瘤对成年同基因BALB/c小鼠进行免疫,可产生可重复的、非同源的与肿瘤特异性移植抗原(TATA)相关的交叉保护,以抵御其他原发性MCA肉瘤或体外传代的MCA肉瘤细胞的攻击。还检测到了同源的、个体特异性的与肿瘤特异性移植抗原(TSTA)相关的保护作用。经辐照的正常BALB/c脾脏或肌肉组织没有类似的保护作用。用二次培养的、体外适应的肉瘤攻击接种物能最好地检测到明显的交叉保护作用,这种接种物可以精确标准化。这些发现与先前报道的长期培养的MCA诱导的肉瘤细胞系具有良好的交叉保护作用相一致。通过同基因过继转移实验测试,在所有同基因的、原发性MCA诱导的肉瘤以及无鼠白血病病毒(MuLv)的MCA诱导的同基因Meth A肉瘤细胞上,肿瘤特异性移植抗原(OFA)都表现为肿瘤特异性移植抗原(TATA)。